⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KNSA News
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
Giant-Cell Arteritis - Market Insights, Epidemiology & Forecast to 2036 | Steroid-Sparing Therapies Reshape GCA Care
globenewswire.com
ABBV
NVS
KNSA
CHTR
Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference
globenewswire.com
KNSA
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
globenewswire.com
KNSA
Form 8-K
sec.gov
KNSA
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
globenewswire.com
KNSA
REGN
Form 8-K
sec.gov
KNSA
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
globenewswire.com
KNSA
Form 8-K
sec.gov
KNSA
Form 8-K
sec.gov
KNSA
Form 8-K
sec.gov
KNSA